Status:
TERMINATED
A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers
Lead Sponsor:
Pfizer
Conditions:
Healthy
Elderly
Eligibility:
All Genders
65-85 years
Phase:
PHASE1
Brief Summary
To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration of multiple, ascending, oral doses to healthy elderly subjects.
Detailed Description
Additional Study Purpose Details: Phase I safety and pharmacokinetics study. Detailed Description: The study was terminated on 11/12/2008. There were no safety findings in this trial that resulted i...
Eligibility Criteria
Inclusion
- Healthy
- Elderly
- 65-85
Exclusion
- Evidence or history of clinically significant unstable disease
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00736528
Start Date
August 1 2008
End Date
September 1 2008
Last Update
February 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Gainesville, Florida, United States, 32608